The Revolving Door of Adenovirus Cell Entry: Not All Pathways Are Equal

The Revolving Door of Adenovirus Cell Entry: Not All Pathways Are Equal

Adenoviruses represent exceptional candidates for wide-ranging therapeutic applications, from vectors for gene therapy to oncolytics for cancer treatments. The first ever commercial gene therapy medicine was based on a recombinant adenovirus vector, while most recently, adenoviral vectors have prove...

Full description

Bibliographic Details
Main Authors: Davor Nestić, Ksenija Božinović, Isabela Pehar, Rebecca Wallace, Alan L. Parker, Dragomira Majhen
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Pharmaceutics
Subjects:
adenovirus
endocytosis
vectors
gene therapy
Online Access:https://www.mdpi.com/1999-4923/13/10/1585

Internet

https://www.mdpi.com/1999-4923/13/10/1585

Similar Items